HealthPhoto: MintExperts Warn Cancer Drug Price Cuts Miss Patented Therapies
Experts have raised concerns that recent price cuts on cancer drugs do not benefit patented therapies, which see no relief. They call for comprehensive, cost-based price controls on all oncology treatments, permanent statutory margin caps across distribution channels, and full scrutiny of company assistance programs to ensure fair pricing and accessibility.
Mint·




